MedTrace Logo

"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19

NCT05249803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2022-02-22

No results posted yet for this study

Summary

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic.

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Conditions

Interventions

COMBINATION_PRODUCT

Patients with COVID-19 Pneumonia

Patients were offered with usual care of COVID-19 in ICU and we did retrospective study

Sponsors & Collaborators

  • FMH College of Medicine and Dentistry

    lead OTHER

Principal Investigators

  • Aijaz Zeeshan K Chachar, MBBS,FCPS · FMH College of Medicine & Dentistry

Eligibility

Min Age
16 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-08-31
Completion
2021-12-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249803 on ClinicalTrials.gov